BioSpace News Archive

BioForest

Silverback Therapeutics to Present Data for Lead Therapeutic Candidate SBT6050 at American Association of Cancer Research Annual Conference

Novel composition design allows for systemic delivery of TLR8 with activity localized to HER2-expressing tumors

February 27, 2019
·
4 min read
Business

CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability

CAC Corporation (Head Office: Chuo-ku, Tokyo; President and CEO: Ryota Nishimori; hereinafter called “CAC”) has signed a partnership agreement with rfxcel Corporation (Head Office: Reno, Nevada, USA; CEO: Glenn Abood; hereinafter called “rfxcel”) in the pharmaceutical traceability field.

February 27, 2019
·
2 min read
Business

Acacia Pharma Group plc Results For The Ended 31 December 2018

Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, announces its results for the year ended 31 December 2018.

February 27, 2019
·
6 min read
Biotech Bay

BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

BioPharmX Corporation (NYSE American: BPMX) (the “Company”), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received a notice on February 25, 2019 from the NYSE American LLC (the “NYSE American”)

February 27, 2019
·
2 min read
Business

Synthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results

Enrollment is Ongoing in Phase 2b Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C; Topline Data Readout Anticipated in 2H 2019

February 27, 2019
·
12 min read
Drug Development

Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data

Late-breaking oral presentation to report preclinical mechanistic and efficacy data for immunotherapy combined with SRA737 + LDG, its Chk1 inhibitor plus low dose gemcitabine (LDG), in small cell lung cancer models

February 27, 2019
·
6 min read
Policy

OtiTopic Granted Two Patents Covering its Dry Powder Inhaled Aspirin for the Treatment of Suspected Myocardial Infarction

OtiTopic, Inc. announced that the U.S. Patent and Trade Office has granted two new patents protecting intellectual property related to its lead candidate, OTI-0726, a novel inhaled rapid-onset aspirin formulation in development for the treatment of suspected myocardial infarction.

February 27, 2019
·
3 min read
MR Solutions’ high-field multi-modality, cryogen-free MRI system on display at EMIM

MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019.

February 27, 2019
·
2 min read
Genetown

Pre-Filled Syringes - Chemical Compatibility and Design Strategies

At SMi’s 2019 Pre-Filled Syringes East Coast USA Conference, industry leaders will meet in Boston to share their insights on best design practice, drug compatibility within the whole supplier chain and challenges with manufacturing and drug delivery.

February 27, 2019
·
2 min read